A feedback loop between androgen receptor and ERK signaling in estrogen receptor-negative breast cancer

Kee Ming Chia1, Ji Liu, Glenn D Francis

  • 1University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

Neoplasia (New York, N.Y.)
|March 16, 2011
PubMed

Insights

Researchers discovered a feedback loop between androgen receptor (AR) and extracellular signal-regulated kinase (ERK) signaling in estrogen receptor-negative breast cancer. This AR-ERK pathway cross-regulation offers new therapeutic targets for this aggressive cancer subtype.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Estrogen receptor (ER)-negative breast cancer is a heterogeneous disease with poorly understood biology.
  • Molecular apocrine breast cancer, an ER-negative subtype, overexpresses androgen receptor (AR) and ErbB2.

Purpose of the Study:

  • To investigate the relationship between AR and extracellular signal-regulated kinase (ERK) signaling pathways in molecular apocrine breast cancer.
  • To elucidate the feedback mechanisms and therapeutic implications of the AR-ERK axis in this cancer subtype.

Main Methods:

  • Utilized an in vivo molecular apocrine model to study AR and ERK pathway interactions.
  • Examined the regulation of ERK phosphorylation and activity by AR.
  • Assessed the role of ErbB2 as a mediator between AR and ERK signaling.
  • Investigated ERK-mediated regulation of AR expression and downstream targets.

Main Results:

  • Identified a positive feedback loop where AR regulates ERK phosphorylation and activity.
  • Demonstrated that AR inhibition down-regulates ERK target proteins.
  • Showed that AR-mediated ERK induction requires ErbB2, and AR regulates ErbB2 expression.
  • Revealed ERK-mediated regulation of AR expression and identified CREB1 as a downstream connector.
  • Found AR-positive staining associated with ERK signaling targets in ER-negative tumors.

Conclusions:

  • Established a significant AR-ERK feedback loop in ER-negative breast cancer, specifically in the molecular apocrine subtype.
  • Highlighted the crucial role of ErbB2 as an upstream connector in this feedback loop.
  • Suggested that targeting the AR-ERK axis holds therapeutic potential for molecular apocrine breast cancer.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...